TCL Archive New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB. October 8, 2004
TCL Archive FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness” September 3, 1976
TCL Archive FDA Nearly Wrecks NCI Drug Distribution Program, Finally Agrees To New Guidelines January 30, 1976
